NCT04026659 (FIXCAS) is a NA clinical trial of Multi-modal exercise in Cancer, sponsored by University of Dublin, Trinity College.

Who is sponsoring NCT04026659?

NCT04026659 is sponsored by University of Dublin, Trinity College.

What drugs are being tested in NCT04026659?

Interventions in NCT04026659: Multi-modal exercise.

Is NCT04026659 still recruiting?

NCT04026659 is currently completed. Last updated 30 November 2020.

Last reviewed 2020-11-30 · How we verify

NCT04026659: FIXCAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Feasibility of Implementing an Exercise Programme for Deconditioned Cancer Survivors

Completed NA Last updated 30 November 2020

What this trial tests

NA trial testing Multi-modal exercise in Cancer in 40 participants. Completed in 31 October 2020.

Timeline

25 September 2019

Primary endpoint
1 October 2020

31 October 2020

Quick facts

Lead sponsor	University of Dublin, Trinity College
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	25 September 2019
Primary completion	1 October 2020
Estimated completion	31 October 2020
Sites	1 location across Ireland

Drugs / interventions tested

Multi-modal exercise

Conditions studied

Cancer — all drugs for Cancer →

Sponsor

University of Dublin, Trinity College

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As both the number of cancer survivors and the length of survival time are increasing, long-term health issues related to cancer and its treatment are becoming more prevalent. Research suggests that exercise can mitigate a number of negative health consequences in cancer survivors and improve physical function and quality of life. Multi-modal exercise interventions have been proposed as a cornerstone for survivorship care. However, studies evaluating exercise programmes within the Irish population are lacking. The aim of the study is to evaluate the introduction, implementation and acceptability of a multi-modal exercise rehabilitation programme for deconditioned cancer survivors in a real-world, standard practice setting.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The feasibility of implementing an exercise programme for deconditioned cancer survivors in a national cancer centre: FIXCAS Study.
Devenney K, Murphy N, Ryan R, Grant C, et al · · 2019 · cited 1× · PMID 33870087 · DOI 10.12688/hrbopenres.12925.2
The feasibility of implementing an exercise programme for deconditioned cancer survivors in a national cancer centre: FIXCAS Study
Devenney K, Murphy N, Ryan R, Grant C, et al · · 2020 · DOI 10.12688/hrbopenres.12925.2

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting

Other University of Dublin, Trinity College trials

Trials by the same sponsor.

NCT07581093 — The REACT Study: REhabilitation and ACTivity in Allogenic Transplant · not yet recruiting
NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
NCT07196020 — Prediction of Venous Thrombosis During chemotherapy-the PINPOINT Study · not yet recruiting
NCT06280885 — A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy · NA · recruiting
NCT06820008 — Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precisio · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04026659 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Dublin, Trinity College
Last refreshed: 30 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04026659.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing